KEGG   DRUG: Pneumococcal 13-valent conjugate vaccineHelp
Entry
D10455                      Drug                                   

Name
Pneumococcal 13-valent conjugate vaccine;
Prevenar 13 (TN)
Class
Antiviral
 DG01686  Inactivated vaccine
Remark
Therapeutic category: 6311
ATC code: J07AL02
Chemical structure group: DG00672
Product (DG00672): D10455<JP>
Efficacy
Active immunization (pneumococcal)
  Disease
Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F [DS:H01321]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AL Pneumococcal vaccines
     J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
      D10455  Pneumococcal 13-valent conjugate vaccine <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6311  Bacterial vaccines
     D10455  Pneumococcal 13-valent conjugate vaccine
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10455
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10455
BRITE hierarchy
Other DBs
PubChem: 172232548
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system